Effectiveness of Internet-based Self-help Cognitive Behavioural Therapy in Reducing Insomnia Among Adult Population

Sponsor
Education University of Hong Kong (Other)
Overall Status
Recruiting
CT.gov ID
NCT05551806
Collaborator
Baptist Oi Kwan Social Service (Other)
210
2
2
19
105
5.5

Study Details

Study Description

Brief Summary

This experimental study aims to develop an internet-based self-help cognitive behavioural therapy for insomnia that reduces insomnia symptoms and its associated adverse outcomes among people with sub-threshold insomnia symptoms. In particular, this study compares the efficacy of internet-delivered self-help CBT-I with the wait-list control group, in treating insomnia in a non-clinical population.

The online CBT-I course will consist of an introductory module, followed by 6 weekly modules. Each module will consist of the main treatment component presented in written or video format, quiz, and homework. Materials will be presented in an interactive manner to facilitate engagement.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Internet-based self-help cognitive behavioural therapy
N/A

Detailed Description

Although the Internet self-help CRT-I program have shown promising effect on dealing with insomnia symptoms, the effectiveness of internet self-help CBT-I in adults with sub-clinical insomnia symptoms in Hong Kong is under-studied. Therefore, the present study aimed to compare the efficacy of internet-delivered self-help CBT-I with the wait-list control group, in treating insomnia in a non-clinical population. We hypothesized that (1) participants who received CBT-I treatment would have improved insomnia symptoms after the intervention as compared with the wait-list controls; (2) participants from CBT-I would have better sleep hygiene, and less dysfunctional beliefs about sleep and pre-sleep arousal after the intervention as compared with the wait-list controls; (3) participants from CBT-I would have improved mental health, daytime functioning, quality of life, and general well-being after treatment, as compared with the wait-list controls.

The online CBT-I course will consist of an introductory module, followed by 6 weekly modules, incorporating the key CBT-I components, including sleep hygiene education, stimulus control, sleep restriction, relaxation training, and cognitive therapy. Each module will consist of the main treatment component presented in written or video format, quiz, and homework. Materials will be presented in an interactive manner to facilitate engagement.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
210 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Internet-based Self-help Cognitive Behavioural Therapy (CBT-I) in Reducing Insomnia Symptoms Among the Adult Population: A Randomized Controlled Trial
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: CBT-I group

Participants in the CBT-I condition start the 6-week CBT-I immediately after randomization, complete the post-intervention assessment right after they finish the treatment, and complete the follow-up assessment 4 weeks after the post-intervention assessment. They will be invited to participate in an interview after completing the post-intervention assessment.

Behavioral: Internet-based self-help cognitive behavioural therapy
The online CBT-I course will consist of an introductory module, followed by 6 weekly modules, incorporating the key CBT-I components, including sleep hygiene education, stimulus control, sleep restriction, relaxation training, and cognitive therapy.

No Intervention: Waitlist control group

Participants in the waitlist control group will wait for 6 weeks without the CBT-I intervention and then complete the post-intervention assessment; while waiting for 4 more weeks and then completing the follow-up assessment. The waitlist control participants will start CBT-I (equivalent to that of the CBT-I group) immediately after completing the follow-up assessment.

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline Assessment in the Severity of Sleep Problem on the Insomnia Severity Index (ISI) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The ISI assesses the change in a 5-point Likert scale, ranging from 1 (none/ very dissatisfied/ not at all noticeable, worried & interfering) to 5 (very severe/ very satisfied/ very much noticeable, worried & interfering).

Secondary Outcome Measures

  1. Change from Baseline Assessment in General Sleep Disturbances on the Pittsburgh Sleep Quality Index (PSQI) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The PSQI assesses the change in a 4-point Likert scale, ranging from 1 (not during the past month/ very good) to 4 (three or more times a week/ very poor).

  2. Change from Baseline Assessment in Daily Sleep-Wake Schedule on the 7-Day Consensus Sleep Diary at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The 7-day consensus sleep diary will calculate the change of participants' sleep parameters from the diary data.

  3. Change from Baseline Assessment in Cognitive and Somatic Manifestations of Arousal on the Pre-sleep Arousal Scale (PSAS) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The PSAS assesses the change in a 5-point Likert scale, ranging from 1 (not at all) to 5 (extremely).

  4. Change from Baseline Assessment in Sleep Habits on the Sleep Hygiene Practice Scale (SHPS) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The SHPS assesses the change in a 6-point Likert scale, ranging from 1 (never) to 6 (always).

  5. Change from Baseline Assessment in Sleep Related Cognition on the Dysfunctional Beliefs and Attitudes about Sleep (DBAS) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The DBAS assesses the change in a 10-point Likert scale, ranging from 0 (strongly disagree) to 10 (strongly agree).

  6. Change from Baseline Assessment in Psychological Wellbeing on the World Health Organisation-Five Well-Being Index (WHO-5) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The WHO-5 assesses the change in a 6-point Likert scale, ranging from 1 (never) to 6 (all of the time).

  7. Change from Baseline Assessment in Psychological Distress on the Short Form of the Depression, Anxiety, and Stress Scale (DASS-21) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The DASS-21 assesses the change in a 4-point Likert scale, ranging from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time).

  8. Change from Baseline Assessment in Quality of Life on the Twelve-Item Short-Form (SF-12) Health Survey at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The SF-12 assesses the change in a combination of 5-point and 3-point Likert scale, ranging respectively from 1 (poor/ never) to 5 (excellent/ very much), and 1 (never) to 3 (very much).

  9. Change from Baseline Assessment in Functional Impairment of Insomnia on the Work and Social Adjustment Scale (WSAS) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The WSAS assesses the change in a 9-point Likert scale, ranging from 1 (not at all) to 9 (very severely).

  10. Change from Baseline Assessment in Cognitive Failure on the Measure of Insight into Cognition-Self Report (MIC-SR) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The MIC-SR assesses the change in a 4-point Likert scale, ranging from 1 (never) to 4 (almost daily).

  11. Change from Baseline Assessment in Expectation toward Intervention on the Credibility of Treatment Rating Scale (CTRS) at Post-Intervention Assessment and Follow-up Assessment [Before intervention, Immediately after intervention, and 4 weeks after intervention]

    The CTRS assesses the change in a 6-point Likert scale, ranging from 1 (not at all confident) to 6 (very confident).

  12. Insomnia Treatment Acceptability assessed the Insomnia Treatment Acceptability Scale (ITAS) at the Interview after Post-Intervention Assessment [Immediately after Post-Intervention Assessment]

    The ITAS assesses the insomnia treatment acceptability in a 10-point Likert scale, ranging from 1 (not at all acceptable) to 10 (very acceptable).

  13. Treatment Adherence at the Interview after Post-Intervention Assessment [Immediately after Post-Intervention Assessment]

    Participants report the number of sessions they had read, how long they had spent on the CBT program, and how far they had followed the instructions.

  14. Treatment Satisfaction at the Interview after Post-Intervention Assessment [Immediately after Post-Intervention Assessment]

    Participants report on whether they like, found it useful, and improvement of the intervention in a 10-point Likert scale, ranging from 0 (not at all suitable) to 10 (very suitable).

  15. Treatment Satisfaction in internet (Acceptability of the Internet for delivering CBT) at the Interview after Post-Intervention Assessment [Immediately after Post-Intervention Assessment]

    Participants report on how suitable, how convenient, how much they liked, and how worried they were about their privacy in a 10-point Likert scale, ranging from 0 (not at all suitable) to 10 (very suitable).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hong Kong residents

  • Age ≥18 years

  • Insomnia Severity Index score > 7 and < 22

  • Being able to read Chinese

  • Have a computer, tablet and/or smartphone device with Internet access

  • have a regular email address

  • Willing to give informed consent and comply with the trial protocol

Exclusion Criteria:
  • Receiving psychological treatment at least once per month

  • Currently taking prescribed psychiatric drugs such as antidepressants, tranquilizers, and sleeping pills regularly

  • Carrying a diagnosis of psychosis or schizophrenia

  • Participating in any other academic studies or clinical trials related to insomnia

  • Having current suicidal plans or acts or having had suicidal plans or acts within the past 12 months

  • Shift workers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Baptist Oi Kwan Social Service Hong Kong Hong Kong 999077
2 The Education University of Hong Kong Hong Kong Hong Kong 999077

Sponsors and Collaborators

  • Education University of Hong Kong
  • Baptist Oi Kwan Social Service

Investigators

  • Principal Investigator: Kevin, Ka Shing CHAN, The Education University of Hong Kong

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
CHAN Ka Shing Kevin, Associate Professor, Head of Department of Psychology, Education University of Hong Kong
ClinicalTrials.gov Identifier:
NCT05551806
Other Study ID Numbers:
  • 2021-2022-0340
First Posted:
Sep 23, 2022
Last Update Posted:
Sep 23, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by CHAN Ka Shing Kevin, Associate Professor, Head of Department of Psychology, Education University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2022